Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?
Clinical Chemistry · 2024
DOI: 10.1093/clinchem/hvae010 ↗Kurz gefasst
Leserbrief in der Zeitschrift Clinical Chemistry, 2024. Verfasst von Supawadee Suppadungsuk und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States. Hauptthemen laut MEDLINE: Demyelinating Diseases, Hyponatremia, Sodium. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
- Chakri Naruebodindra Medical Institute, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Samut Prakan, Thailand.
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, MN, United States.
ORCID-Profile: Kianoush Kashani
Zitieren
APA
Suppadungsuk, S., & Kashani, K. (2024). Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?. Clinical Chemistry. https://doi.org/10.1093/clinchem/hvae010
Vancouver
Suppadungsuk S, Kashani K. Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?. Clinical Chemistry. 2024. doi:10.1093/clinchem/hvae010
BibTeX
@article{Suppadungsuk2024,
author = {Suppadungsuk, Supawadee and Kashani, Kianoush},
title = {Osmotic Demyelination Syndrome in Hyponatremia: Does the Rate of Sodium Correction Matter?},
journal = {Clinical Chemistry},
year = {2024},
doi = {10.1093/clinchem/hvae010}
}
EUVIMED